HIGH logo

Cantourage Group
HIGH

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€42.27M
EV
€42.09M
Shares Outstanding
12.47M
Beta
0.03
Industry
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
2
P/E 2025E
33.90x
P/Revenue 2025E
0.47x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
33.00%
Net Profit Margin 2025E
1.43%
ROE 2025E
3.50%
ROCE 2024
0.18%

Dividends

DPS 2025E
-
Payout Ratio 2025E
-
Div. Yield 2025E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Cantourage Group SE

gainify
HIGH logo

Cantourage Group SE

HIGH

Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany.

Sector

Industry

CEO

Schetter, Philip

Employees

7

IPO Date

Headquarters

Heinrich-Mann-Str. 12, Kleinmachnow, Brandenburg, 14532, Germany

📊 Stock Price & Performance

Review the recent HIGH stock performance trends:Past 3 Months: The stock has +6.03%. Last updated: January 1, 2026 at 12:21 AM Eastern Time

Cantourage Group (HIGH) is considered a low volatility stock. It has a beta of 0.03, which means it typically moves 0.03 times as much as the broader market. Last updated: January 1, 2026 at 12:21 AM Eastern Time

Based on current HIGH analyst forecasts and market assumptions, the consensus price target for Cantourage Group (HIGH) is €8.25 for 2027. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated:

💰 Financial Metrics & Reports

The current Cantourage Group (HIGH) market capitalization is approximately €42.27M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Cantourage Group's market cap fluctuates with changes in its share price and share count. Last updated: January 1, 2026 at 12:21 AM Eastern Time

In the most recently reported quarter, Cantourage Group (HIGH) generated €411.72K in revenue, representing a -8.31% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 4:31 AM Eastern Time

In the most recently reported fiscal year, Cantourage Group (HIGH) generated net income of €79.29K, compared with €-4.27M in the prior fiscal year, representing a -101.86% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of €1.30M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 4:31 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Cantourage Group (HIGH) revenue was €411.72K. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 4:31 AM Eastern Time

Cantourage Group (HIGH) does not currently pay a dividend. Over the last twelve months (LTM), the company paid €0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 4:31 AM Eastern Time

📈 Analyst Information

Analyst assessments of whether Cantourage Group (HIGH) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Consensus price target: €8.25Implied return: +180.82% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated:

Based on the latest available analyst coverage, Cantourage Group (HIGH) currently carries a Buy consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated:

Like other publicly traded stocks, Cantourage Group (HIGH) shares are bought and sold on stock exchanges such as XTRA and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Cantourage Group (HIGH) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add HIGH to your watchlist.

Cantourage Group trades under the ticker symbol HIGH on the XTRA stock exchange. The ticker HIGH is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Cantourage Group (HIGH) employs approximately 7 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: January 1, 2026 at 12:21 AM Eastern Time

Cantourage Group (HIGH) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Cantourage Group (HIGH) stock peers based on overlapping products, services, and competitive dynamics:China SXT Pharmaceuticals (SXTC)RAMM Pharma (RAMM)Klaria Pharma Holding AB (publ.) (KLAR) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Cantourage Group.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.